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of PJI should be mandatory for each surgeon that is involved in 
knee arthroplasty. Optimization of modifiable variables that may 
influence this risk is also critical. A recent study by Namba et al.1) 
evaluated 56,216 total knee arthroplasty (TKA) surgeries. The 
study found an incidence of deep infection of 0.72% (404/56,216). 
The risk factors for infection were body mass index (BMI) of 
≥35 (hazard ratio [HR], 1.47), diabetes mellitus (HR, 1.28), male 
sex (HR, 1.89), an American Society of Anesthesiologists (ASA) 
score of ≥3 (HR, 1.65), osteonecrosis (HR, 3.65), and posttrau-
matic arthritis (HR, 3.23). Hispanic race was a protective factor 
(HR, 0.69), the use of antibiotic irrigation (HR, 0.67), a bilateral 
procedure (HR, 0.51), and a lower annual hospital volume (HR, 
0.33). Surgical risk factors included quadriceps-release exposure 
(HR, 4.76), and the use of antibiotic-laden cement (HR, 1.53). 
Operative time was a risk factor, with a 9% increased risk per 
fifteen-minute increments. Although some risk factors found in 
this study are debatable, the study highlights some of the impor-
tant predisposing factors for infection.
Obesity and diabetes are both well-known risk factors for knee 
PJI. According to the American Association of Hip and Knee 
Surgeons (AAHKS), prior to surgery, a patient with a BMI over 
40 should be counseled regarding weight loss2). In addition, 
AAHKS has emphasized the importance of a nutritional evalua-
tion prior to surgery2). Regarding diabetes, a large Finnish study 
corroborated its relevance as a strong risk factor for infections3). 
Although Hemoglobin A1C has been used to evaluate arthro-
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Introduction
It is well recognized that a periprosthetic joint infection (PJI) 
after knee arthroplasty is a catastrophic complication not only for 
the patient, but also for the health-care system. During the last 
decade, clinical research has considerably improved our compre-
hension of this topic. However, we are still in the process of pro-
ducing high-level evidence to support our daily clinical practice. 
In this article we will review ten strategies that work in managing 
knee PJI. 
1. Preoperative Risk Stratification
From our standpoint, the first step to succeed in the battle 
against knee PJI is prevention. Consequently, in order to stratify 
the patient’s risk, knowledge of risk factors in the development 
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plasty patients, a recent publication from Iorio et al.4) showed 
that it is probably a suboptimal preoperative measurement due 
to its inability to prognosticate complications. We believe that an 
exhaustive preoperative evaluation, and glycemic level optimiza-
tion is an indispensable component of the preoperative work up, 
and must be conducted by a general internist, or medicine sub-
specialist. Currently, the evidence is not able to present a definite 
threshold regarding BMI and glycemic control in order to estab-
lish a clear preoperative recommendation for knee arthroplasty 
patients.
Another attractive strategy is to calculate a preoperative risk of 
PJI using a scoring system. The Mayo Clinic recently presented a 
prosthetic joint infection risk score, which demonstrated a good 
capacity to discriminate subjects who will develop a PJI from 
those who will not (C-index of 0.722)5). It includes the BMI, pres-
ence of prior operations on the index joint, prior arthroplasty, 
immunosuppression, ASA score, and procedure duration5). After 
adding postoperative wound drainage to the previous variables, 
the 1-month post surgery risk score presents a C- index of 0.716.
A recent study conducted in Korea described a prevalence of 
surgical site infections (SSI) in 161 of 6,848 cases (2.35%)6). Inter-
estingly, the authors suggested that the risk factors for SSI differ 
between total hip arthroplasty (THA), and TKA. Independent 
risk factors for SSI in TKA were male gender, and an operating 
room without laminar flow. More than 10 procedures per month 
was a protective factor for knee PJI6).
A recent systematic review and meta-analysis indicate that, 
compared with osteoarthritis (OA) patients, patients with rheu-
matoid arthritis have a higher risk of infection following TKA7).
Another important risk factor is revision surgical procedures8). 
A study from our institution revealed that the risk of infection 
among patients undergoing revisions was 10-fold higher (9%)8) 
than for patients undergoing primary TKA (0.5%−1%)9). The risk 
was predicted by factors such as revision due to infection, higher 
Charlson comorbidity index, and diagnosis other than OA at the 
time of the primary procedure. 
Understanding the risk factors for PJI, allows implementation 
of strategies that aims to reverse some of these potential risk fac-
tors and reduce the burden of infection.
2. Preoperative Antibiotics
One of the most effective strategies for the prevention of infec-
tion in modern orthopaedic literature is the administration of 
preoperative antibiotics10,11). In order to achieve optimal results, 
adequate concentration of antibiotics should be present during 
the entire time the incision is open, when the greatest risk for 
contamination is present10). For predictable and rapid delivery 
of antibiotics, systematic intravenous (IV) administration is the 
method of choice12).
Conflicting opinions exist as to what the optimal time window 
for prophylaxis administration should be12). Some studies have 
shown that the best time for administration is within 30 minutes 
of incision13), while others support administration within 30−59 
minutes14). Based on The American Academy of Orthopaedic 
Surgeons (AAOS) and The Centers for Disease Control (CDC) 
guidelines, prophylactic antibiotics should be administered 
within one hour before the surgical incision15). When a proximal 
tourniquet is used, administration of the entire dose of antibiotic 
should occur before inflation of the tourniquet12,15). Duration of 
antibiotic coverage should not exceed 24 hours postoperatively15), 
doing so may increase the risk for adverse effects of antibiotics 
without proven benefits15,16). Avoiding unnecessary antibiotic use 
will also minimize the risk ofbacterial resistance17). Furthermore, 
intraoperative dose of antibiotic should be repeated if there is 
significant blood loss, or if operative time exceeds two times the 
half-life of antibiotic15,18).
Currently, the most widely used prophylactic antibiotics for 
prevention of PJI are first and second generation cephalosporins 
because of their excellent tissue penetration, bioavailability, and 
coverage against common organisms such as Staphylococcus spe-
cies, and enteric pathogens12). In patients undergoing orthopaedic 
procedures, cefuroxamine and cefazolin are the preferred antibi-
otics14). These antibiotics may not be appropriate in certain cases, 
and the addition of vancomycin may be warranted12,15). AAOS 
guidelines recommend vancomycin in facilities with methicillin-
resistant staphylococcus aureus (MRSA) outbreaks, and in pa-
tients with known MRSA colonization15). Additionally, vancomy-
cin should be considered in institutionalized patients (dialysis-
dependent patients and nursing home residents), and health care 
workers12). Patients with a documented anaphylactic reaction 
to penicillin can either receive clindamycin or vancomycin12,15), 
however, our institution prefers vancomycin to avoid the poten-
tial for clindamycin-associated clostridium difficile enteritis12).
3. Skin Preparation
Preoperative skin preparation is of common practice in the or-
thopaedic community. Skin preparation prior to surgery includes 
skin decolonization, antisepsis, hand washing by the surgeon, 
and hair removal. Ample evidence exists in support of the role of 
preoperative cleansing in reduction of skin bacteria load19,20), but 
how this translates to prevention of SSI is unclear.
Preoperative showering or cleansing with an antiseptic agent at 
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least the night before a surgical procedure has been recommend-
ed by the CDC21). In two prospective consecutive series, patients 
who used chlorhexidine gluconate (CHG) impregnated wipes the 
night before, and the morning of the surgery had a lower inci-
dence of SSI as compared with those who did not comply to the 
protocol in both THA and TKA procedures. In contrast, a Co-
chrane review of 7 randomized trials concluded that preoperative 
showering with CHG did not reduce the rate of SSI as compared 
to a no shower group or placebo group22). Despite conflicting 
data regarding preoperative showers reducing SSI incidence, the 
simplicity and cost-effectiveness of this method justifies its cur-
rent recommendation23).
Regarding skin preoperative disinfection, the discussion has fo-
cused on the selection of an optimal antiseptic agent12). The main 
types of antiseptic agents are: alcohol based solutions, povidone-
iodine and CHG24,25). In studies comparing CHG and povidone-
iodine the results are conflicting. Darouiche et al.26) demonstrated 
that CHG in alcohol was superior in reducing the rate of SSI as 
compared to aqueous povidone-iodine. However, the iodine 
preparation in the study did not use an alcohol solvent, hence 
allowing for the possibility that alcohol may play a role. In fact, 
in a study involving general surgery patients, povidone-iodine 
prepped patients had a lower rate of SSI when alcohol was used 
(either as a solvent or scrub)27). Overall, the literature suggests 
some value in the combination of alcohol with antiseptic agents, 
and that CHG combined with alcohol may be superior to other 
combinations26,28,29).
In regards to preoperative hair removal, the CDC recommends 
that it should be done immediately before the procedure, and 
electric clippers are preferred over razor blades12,21). Tanner et 
al.30) conducted a meta-analysis that showed that electric clippers 
were associated with fewer SSIs than with razor shaving.
Hand washing by the surgeon and medical personnel is a diffi-
cult topic to evaluate due to the variability in the literature regard-
ing duration, and optimal antiseptic agent. One study examining 
surgical scrub time, and subsequent bacterial growth found no 
significant difference between a 2 or a 3 minute scrub31). Cur-
rently, The Association of Perioperative Registered Nurses states 
that a 3−4 minute scrub is as effective as a 5 minute scrub, while 
the CDC recommends 2−5 minutes21). Data on hand rub (alcohol 
based) and hand scrub agents suggest no significant difference 
in efficacy between the two32). A trial of 4,387 patients who un-
derwent clean, and clean contaminated surgery using either tra-
ditional hand scrubbing techniques or waterless, alcohol-based 
antiseptics showed no difference in SSI rates33). Based on current 
literature, medical personnel should consider a minimum dura-
tion of 2−3 minutes for surgical hand antisepsis using either hand 
rub or hand scrub solution31-33).
4. Diagnosis of Periprosthetic Joint Infection 
The diagnosis of PJI should be suspected in all patients evalu-
ated for a painful TKA. The AAOS established diagnostic guide-
lines that help identify PJI of the knee34). The measurement of 
serum markers such as C-reactive protein (CRP), and the eryth-
rocyte sedimentation rate (ESR) is highly valuable in reaching a 
diagnosis of PJI. It must be noted that these tests are not diagnos-
tic independently. According to the AAOS34) and the Infectious 
Diseases Society of America guidelines35), if serum markers are 
elevated, a joint aspiration should be performed. Our institution 
always includes cytochemical fluid analysis, and two cultures 
after every knee aspiration. More recently, we have added the 
evaluation of the leukocyte esterase test also36).
We encourage the surgeons to be cognizant of the Musculosk-
eletal Infection Society (MSIS) PJI diagnostic criteria, that aim to 
provide a standard definition of PJI37). The criteria can be used as 
a guide to establish a diagnosis when PJI is suspected. Taking into 
consideration the benefits, costs and risks of different strategies of 
PJI diagnosis, the use of serum markers followed by knee arthro-
centesis is a highly efficient strategy.
A recent study from our group determined the thresholds for 
serum markers to diagnose PJI using the MSIS criteria. In early 
postoperative knee PJI, the ESR threshold was 54 mm/hour, and 
CRP was 23.5 mg/L. In late-chronic knee PJI the thresholds were 
46.5 mm/hour for ESR, and 23.5 mg/L for CRP38). A study from 
another group established that the rate of false negatives was 9.2% 
for ESR, 5.3% for CRP, and 11% for combined ESR and CRP 
when diagnosing knee PJI. The authors believe that one of the 
factors that may explain these observations is that some patients 
may not mount a sufficient immune response, especially in early 
postoperative infections39). For this reason, a joint aspiration 
should be conducted even if serum markers are normal in those 
cases with high clinical suspicion, or known risk factors for knee 
PJI.
Our group also presented the value of studying the CRP in the 
synovial fluid, which may be an additional tool to improve our 
diagnostic alternatives40).
5. Intraoperative Assessment in Every Revision Case
From our standpoint and according to the recommendations 
made by the AAOS, surgeons should always perform a PJI diag-
nostic workup in every revision case. This process should start 
when the decision to undergo a revision is made, and the strate-
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gies described above are used. Once the patient is in the opera-
tion room, three main strategies can be employed: 1) cultures, 2) 
frozen sections, and 3) implant-related studies.
Concerning intraoperative cultures, one of the most important 
steps is to not withhold the preoperative antibiotics in revision 
cases. A multicenter randomized study, demonstrated that in-
traoperative cultures yielded the same organisms as preopera-
tive cultures in 28 of 34 patients (82%) randomized to receive 
antibiotics before the skin incision compared to 25 of 31 patients 
(81%) randomized to receive antibiotics after obtaining opera-
tive cultures41). In regards to the type of cultures that should be 
obtained during the surgery, a study conducted in our institution 
demonstrated that tissue cultures are better than swab cultures. 
Tissue cultures demonstrated higher sensitivity, specificity, posi-
tive predictive value (PPV), and negative predictive value (NPV) 
for diagnosing PJI than swab cultures. Swab cultures had more 
false-negative and false-positive results than tissue cultures42) An-
other important strategy is to obtain the synovial fluid culture in 
blood culture flasks, due to its higher sensitivity, specificity, and 
both PPV and NPV for diagnosis of PJI when compared with 
standard tissue and swab samples43).
Regarding the use of frozen sections, it must be noted that they 
represent one of the diagnostic criteria in the MSIS definition. 
A recent systematic review and meta-analysis by Tsaras et al.44) 
showed that intraoperative frozen sections are helpful in the di-
agnosis of culture-positive PJI, but had moderate accuracy in rul-
ing out this diagnosis. According to the authors, frozen section is 
especially valuable if the suspicion of infection remains high even 
after a negative preoperative evaluation. The optimum diagnostic 
threshold (number of polymorphonuclear leukocyte per high-
power field) could not be discerned in this study.
Implant sonication is proving to be an interesting technology45). 
Its role has not been completely determined in the diagnostic 
work-up of PJI, especially considering the costs associated.
6. How to Improve the Utility of Cultures?
Cultures of tissue and synovial fluid obtained from an affected 
joint play a major role in both the diagnosis and treatment of 
PJI12). These cultures are used to confirm, and not to screen for 
PJI12). Currently, diagnosis of PJI can be made from two separate 
fluid or tissue samples from an affected joint37). Not only do cul-
tures confirm a PJI diagnosis, they also allow for sensitivity-guid-
ed treatment. However, in 7% to 12% of PJI cases cultures may be 
negative even when clear signs of infection are present46,47).
Negative cultures may be caused by a variety of reasons, in-
cluding inappropriate collection of sample, use of antimicrobial 
therapy prior to collection, short incubation duration, and pos-
sible fungal or mycobacterial infection12). In the setting of a true 
PJI, negative cultures limit the ability to tailor antibiotic treatment 
and may hinder justification for revision surgery12). Thus, atten-
tion should be directed at decreasing the incidence of negative 
cultures.
Strategy for obtaining positive cultures includes withholding 
aspiration of joints for at least two weeks prior to sample collec-
tion, followed by a prolonged period of incubation12,46). A study 
by Schaefer et al.48) described that prolonged incubation for at 
least 14 days increased the identification of organisms that would 
otherwise remain culture negative. Certain pathogens that are 
difficult to isolate using traditional cultures include fungi, myco-
bacteria, and organisms encapsulated in biofilm46). Proper media 
should be used in cases where fungi or mycobacteria are sus-
pected12). A repeat aspiration should be considered in the event of 
inconclusive preoperative aspiration, negative cultures, elevated 
inflammatory markers, and high PJI suspicion12).
7. Irrigation and Debridement: When and How?
The use of irrigation and debridement (I&D) with or without 
modular exchange as an appropriate alternative for treatment of 
PJI remains controversial. This less invasive procedure is com-
monly used despite its rate of success ranging between 0% and 
89%49). I&D provides the option for a less complex surgery, and 
lower cost when compared to two-staged procedures50). The po-
tential advantages of I&D over two-stage exchange justify its con-
tinued practice and further investigation of factors that predict its 
optimal use.
I&D has been considered a viable option for early postoperative 
or late hematogenous infections51). Previous studies have suggest-
ed that the ability of I&D to control infection may be related to its 
timing relative to index total joint arthroplasty, and duration of 
symptoms52-54). Hartman et al.52) found significant improvement 
in I&D success rates if used within 4 weeks of index knee surgery. 
In addition to short duration of symptoms, the literature suggests 
a higher I&D success rate in healthier patients, and in infections 
with low virulent organisms55-58). Azzam et al.59) described that 
patients with a higher ASA score, had higher failure rates. Fur-
thermore, several studies recognize Staphylococcal infections as a 
risk factor for failure in I&D60). Thus, I&D should be considered 
in immunologically optimized patients with acute onset of symp-
toms infected with low virulent organisms.
Once the decision to perform an I&D procedure is made, pre-
operative optimization of the patient should be attempted before 
proceeding12). In the operating room, aggressive debridement 
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of all foreign and affected periarticular tissue should be per-
formed12). At our institution, retained components are scrubbed 
with Dakin’s solution and using a new, clean instrument for each 
collection, at least 3 tissue samples are then obtained12). Thorough 
irrigation using low pressure pulse lavage or bulb irrigation of 
the joint with up to 9 liters of solution is performed12,61,62). Finally, 
gloves, gowns and surgical setup should be changed between the 
I&D procedure, and the modular component exchange12).
8. Revision in One Stage: When and How?
One-stage exchange arthroplasty for PJI has become the subject 
of interest due to potential advantages over two-stage exchange. 
Main advantages that proponents focus on are the need for a 
single operation, decreased morbidity, lower cost, and improved 
functional results63-65). Regarding efficacy of the procedure, sev-
eral retrospective studies have reported rates of infection control 
between 73% and 93%66-69).
Although advantages may exist in one-stage exchange, studies 
emphasize that success of the procedure depends on both pa-
tient, and infection related factors12). Jackson and Schmalzried70) 
performed a literature review to determine when single-stage 
exchange is most successful in the setting of an infected hip. Vari-
ables associated with successful outcomes included the absence of 
wound complications after index THA, healthy patients, presence 
of methicillin-sensitive organisms, and organism susceptibility 
to antibiotic-laden bone cement70). Factors that predicted failure 
included polymicrobial infection, presence of gram negative or-
ganisms, and methicillin-resistant organisms70). Furthermore, the 
following may be considered contraindications: systemic infec-
tion, severe soft tissue involvement, inability to identify a micro-
organism preoperatively, and presence of a sinus tract10,12,35,70-72). 
Identifying ways to optimize results of one-stage exchange helps 
determine appropriate indications. At our institution, indications 
for one-stage exchange include: a healthy host, acute postopera-
tive infection, susceptible organism, and adequate soft tissue cov-
erage12).
In one-stage exchange arthroplasty, a patient undergoes a radi-
cal synovectomy, debridement of infected tissue and removal of 
foreign material (including prosthesis and cement)65). Multiple 
cultures should be taken for final culture analysis12). Prior to 
the reimplantation of the prosthesis, the patient should be re-
prepped, and a change of gloves and surgical instruments should 
occur65). After implantation of the antibiotic impregnated ce-
ment, the wound is irrigated with dilute betadine solution before 
final closure65). Systemic antibiotics are usually given for a total of 
6 weeks, beginning with 2 weeks of IV antibiotics followed by 4 
weeks of oral antibiotics65).
9. Revision in Two Stages: When and How?
The two-stage exchange arthroplasty is currently the most ac-
cepted procedure for the treatment of PJI in North America73-75). 
Two-stage exchange involves resection of the implants, me-
ticulous debridement and irrigation, placement of a temporary 
antibiotic-impregnated cement spacer, and delayed component 
reimplantation12,65). Although the main role of two-stage revision 
has been in chronic PJI management, it is increasingly considered 
in cases of acute PJI where initial I&D or one-stage exchange pro-
cedures have failed12,76). Literature on two-stage exchange reports 
variable success rates, and sufficient data directly comparing it to 
one-stage revision is lacking. However, a recent systematic review 
demonstrated an average success rate of 90% after two-stage ex-
change for knee prosthesis infection75). The study also reported 
that two-stage exchange provided better outcomes than one-stage 
revision for septic knee prosthesis75).
Currently, there is insufficient data to provide clear indications 
for two-stage exchange35,70,72). Infections with resistant organisms 
have been associated with higher failure rates in the treatment of 
PJI77,78). Some studies suggest that two-stage exchange may be the 
preferred treatment for highly virulent organisms79,80). Parvizi et 
al.79) examined surgical treatment success of knee and hip MRSA 
infections, and reported infection control by I&D and two-stage 
exchange as 37% and 75% respectively, suggesting superior out-
comes with the latter. Furthermore, Oussedik et al.64) reported 
significant bone loss, and soft-tissue compromise as factors in fa-
vor of a two-stage exchange over a one-stage revision. Insufficient 
soft-tissue coverage may be an indication for two-stage exchange, 
especially if time is required for flap development. Currently at 
our institution, common indications for this procedure are as fol-
lows: chronic PJI, failed I&D, and acute infections associated with 
an immunocompromised host or virulent organism12).
Two-stage exchange begins with thorough removal of infected 
tissue and foreign material, followed by irrigation12). The first 
stage involves insertion of either a static or dynamic antibiotic-
impregnated spacer12), most commonly using vancomycin, to-
bramycin, and gentamicin as the antibiotic12,81). Postoperatively, 
the patient receives a course of antibiotic treatment, usually for 
6 weeks82), followed by reimplantation of a new prosthesis when 
the clinician deems the infection resolved12,83-85). A combination 
of clinical judgment, aspiration, and serological data can aid the 
clinician’s decision on appropriate time for reimplantation12,82).
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10. Patient Information about Their Prognosis
A patient diagnosed with a knee PJI should be informed about 
the prognosis. Providing information is key in maintaining re-
alistic expectations, and avoiding medicolegal issues. Ideally, the 
patient’s family should also be involved during the presentation 
of prognostic information.
Although the term “successful treatment” in PJI has been widely 
used, until recently, its definition was non-uniform. Our group 
found more than 10 different definitions of success in the current 
literature86), thus, we decided to create a Delphi-based consensus 
definition. The study was published recently86), and it described 
success as 1) infection eradication (characterized by a healed 
wound without fistula, drainage, or pain), and no infection re-
currence caused by the same organism strain, 2) no subsequent 
surgical intervention for infection after reimplantation surgery; 
and, 3) no occurrence of PJI-related mortality (by causes such as 
sepsis, necrotizing fasciitis). We expect that in the near future this 
definition will help us better present prognostic information, and 
the overall probability to succeed to optimize patient understand-
ing.
In terms of infection eradication, according to a meta-analysis 
by Jamsen et al.87), the failure to eradicate infection after treatment 
of a periprosthetic knee infection ranged from 0%−31%. Recur-
rent infections occurred in 0%−18%, and new infections varied 
from 0%−31%87). Regarding functional outcomes, Barrack et 
al.88), in a multicenter study of surgical outcomes following revi-
sion knee arthroplasty, patients demonstrated a lower Knee Soci-
ety Score (KSS) in their cohort of septic revisions compared with 
revisions for aseptic failure. Concerning the radical management 
of failed TKA infection treatment, Chen et al.89) demonstrated 
that patients with knee fusions had better functional scores than 
knee amputations.
In TKA revisions, Barrack et al.88) demonstrated that revisions 
due to infection had no differences regarding patients’ satisfac-
tion compared with aseptic revision cases. This fact has been sup-
ported in a subsequent study by Patil et al.90). 
Conclusions
Knee PJI is a devastating complication that is faced by every 
knee arthroplasty surgeon. We suggest that PJI should be com-
bated in an organized way, establishing institutional or even na-
tional protocols in order to decrease the variability in its preven-
tion and management. Based on current knowledge, we highly 
recommend the inclusion of these ten strategies as preoperative, 
intraoperative, and postoperative measures to minimize the risk 
and consequences of periprosthetic knee infection. 
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